Logo image of CRSP

CRISPR THERAPEUTICS AG (CRSP) Stock Analyst Ratings

NASDAQ:CRSP - Nasdaq - CH0334081137 - Common Stock - Currency: USD

47.91  -2.52 (-5%)

After market: 47.67 -0.24 (-0.5%)

Buy % Consensus

75

ChartMill assigns a Buy % Consensus number of 75% to CRSP. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 81.73. This target is 70.6% above the current price.
CRSP was analyzed by 34 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about CRSP.
In the previous month the buy percentage consensus was at a similar level.
CRSP was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.
CRSP Historical Analyst RatingsCRSP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -98 -89 -80 -71 -62 -53 -44 -35 -26 -17 -8 10 20 30

Price Target & Forecast

Price Low Median Mean High 47.9132.3266.3081.73281.40 - -32.54% 38.38% 70.60% 487.35%
CRSP Current Analyst RatingCRSP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2025-02-19 Cantor Fitzgerald Reiterate Neutral -> Neutral
2025-02-18 Citigroup Maintains Buy -> Buy
2025-02-14 Evercore ISI Group Upgrade In-Line -> Outperform
2025-02-14 Morgan Stanley Maintains Underweight -> Underweight
2025-02-13 Chardan Capital Maintains Buy -> Buy
2025-02-13 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-02-13 Stifel Maintains Hold -> Hold
2025-02-13 Goldman Sachs Maintains Neutral -> Neutral
2025-02-13 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-12 Needham Reiterate Buy -> Buy
2025-02-12 RBC Capital Maintains Sector Perform -> Sector Perform
2025-02-12 Barclays Maintains Equal-Weight -> Equal-Weight
2025-02-12 Truist Securities Maintains Buy -> Buy
2025-02-03 HC Wainwright & Co. Initiate Buy
2025-01-14 Needham Reiterate Buy -> Buy
2025-01-07 B of A Securities Maintains Buy -> Buy
2024-12-20 JMP Securities Reiterate Market Outperform -> Market Outperform
2024-12-10 Chardan Capital Maintains Buy -> Buy
2024-11-06 Needham Reiterate Buy -> Buy
2024-11-06 RBC Capital Reiterate Sector Perform -> Sector Perform
2024-11-06 Barclays Maintains Equal-Weight -> Equal-Weight
2024-10-04 RBC Capital Maintains Sector Perform -> Sector Perform
2024-08-12 Truist Securities Maintains Buy -> Buy
2024-08-08 Cantor Fitzgerald Reiterate Neutral
2024-08-06 Chardan Capital Maintains Buy -> Buy
2024-08-06 Needham Maintains Buy -> Buy
2024-08-06 RBC Capital Maintains Sector Perform -> Sector Perform
2024-08-06 Stifel Maintains Hold -> Hold
2024-08-06 Barclays Maintains Equal-Weight -> Equal-Weight
2024-06-27 Needham Reiterate Buy -> Buy